KNOXVILLE, Tenn., May 05, 2026 (GLOBE NEWSWIRE) -- Trillium Renewable Chemicals (Trillium) (www.trilliumchemicals.com), a bio-based chemical manufacturer, announced today that it has raised a $13 million Series B financing round. The financing was led by HS Hyosung Advanced Materials with participation from Capricorn Partners. This funding builds on the company's previous $10.6 million Series A financing round and non-dilutive $2.5 million award from the U.S. Department of Energy.

Following a successful multi-year pilot program validating its glycerol-to-acrylonitrile technology, Trillium selected INEOS Nitriles' Green Lake facility to host the world's first demonstration plant (deemed "Project Falcon") for the manufacture of 100% bio-based acrylonitrile. Construction of Project Falcon is complete, marking the first industrial-scale deployment of Trillium's technology. Commissioning is scheduled for the second quarter of 2026, with product shipments to follow later this year. The capital raised funds: 1) the design and construction of Falcon (completed), 2) Falcon's operation, 3) continued ...